News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
IASLC Announces FDA Accelerated Approval of Emrelis for Advanced NSCLC
Photo: Depositphotos
May 16, 2025, 06:13

IASLC Announces FDA Accelerated Approval of Emrelis for Advanced NSCLC

International Association for the Study of Lung Cancer (IASLC) posted on LinkedIn:

“FDA Accelerated Approval Alert

The FDA has granted accelerated approval to telisotuzumab vedotin-tllv (Emrelis) for adults with advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) showing high c-Met protein expression—after prior systemic treatment.

Based on the LUMINOSITY trial

• 35% overall response rate.
• Median duration of response: 7.2 months.

Why this matters for lung cancer care:

• Offers a new option for patients with high c-Met protein expression.
• Fills a treatment gap for previously treated NSCLC patients.
• Highlights the impact of biomarker-driven therapies.

Learn more.”

More posts featuring NSCLC.

cancer FDA IASLC LUMINOSITY trial NSCLC OncoDaily Oncology
Special Coverage
Blog
May 16, 2025, 06:13
IASLC Announces FDA Accelerated Approval of Emrelis for Advanced NSCLC
Blog
May 16, 2025, 06:06
Tatiana Erazo: Reflections on ISMRC 2025 and Global Collaboration in Minimal Residual Cancer Research
Blog
May 16, 2025, 06:00
Kimryn Rathmell: Beyond the Headlines - The Real Impact of Early Onset Cancer
Cancer Types
May 16, 2025, 05:50
Cervical Cancer: Symptoms, Causes, Stages, Diagnosis and Treatment
Blog
May 16, 2025, 05:47
Stephanie Graff: Brown Medicine's Research Team Presents at ESMO Breast Cancer Congress 2025
Blog
May 16, 2025, 05:40
Killian Maudet: Honored to Attend ISMRC2025
Blog
May 16, 2025, 05:32
Miriam Mutebi Reflects on Ubuntu and African Philanthropy in Cancer Care
Blog
May 16, 2025, 05:21
Filippo Alongi: Honored to be Invited Speaker at 67th ESTRO Annual Meeting in San Francisco
Blog
May 16, 2025, 05:16
Join the ECLIPTIC Programme co-organised by ESO and EONS - European School of Oncology
Blog
May 16, 2025, 05:13
Paolo Tarantino: Davide Massa Presented Interesting Retrospective Analysis at ESMO Breast 2025
Insight
May 16, 2025, 05:02
Kate Collier and Logan Roof Received Awards on Research at the Department of Internal Medicine Meeting 2025
Insight
May 16, 2025, 04:46
Texas Children’s and UT MD Anderson announced $150M Gift from Kinder Foundation to Launch Kinder Children’s Cancer Center